Evaluation of the Safety and Effectiveness of Aceclidine (LNZ101) and Aceclidine + Brimonidine (LNZ100) in the Treatment of Presbyopia

NCT05431543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

59

Enrollment

OTHER

Sponsor class

Conditions

Presbyopia
Refractive Errors
Eye Diseases

Interventions

DRUG: Aceclidine+Brimonidine combination ophthalmic solution
DRUG: Aceclidine ophthalmic solution
DRUG: Vehicle proprietary ophthalmic solution

Sponsor

LENZ Therapeutics, Inc